1. "Adult Leukemia"
  2. "Olga Guryanova"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (6)
Groups
  1. Adult Leukemia (16)
  2. Center for Hematologic Malignancies (16)
  3. Department of Medicine (16)
  4. Executive Committee, Center for Hematologic Malignancies (16)
  5. GSK Faculty (16)
  6. Hematologic Malignancies, Division of (16)

More Groups

People
  1. Olga Guryanova (16)
  2. Ross Levine (16)
  3. Matthew Keller (6)
  4. Omar Abdel-Wahab (6)
  5. Barbara Spitzer (5)
  6. Kaitlyn Shank (5)

More People

Years
  1. 2017 (1)
  2. 2016 (3)
  3. 2015 (3)
  4. 2014 (4)
  5. 2013 (2)
  6. 2012 (2)

More Years

Publications
  1. Blood (5)
  2. Haematologica (2)
  3. Cancer Cell (1)
  4. Cancer Discovery (1)
  5. Genome Biology (1)
  6. Journal of Experimental Medicine (1)

More Publications

Publishers
  1. American Society of Hematology (5)
  2. Nature Publishing Group (3)
  3. American Association for Cancer Research (2)
  4. Ferrata Storti Foundation (2)
  5. Biomed Central Ltd (1)
  6. Cell Press (1)

More Publishers

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Epigenetic identity in AML depends on disruption of nonpromoter regulatory elements and is affected by antagonistic effects of mutations in epigenetic modifiers
    Journal Article

    Glass, J. L.; Hassane, D.; Wouters, B. J.; Kunimoto, H.; Avellino, R.; Garrett-Bakelman, F. E.; Guryanova, O. A.; Bowman, R.; Redlich, S.; Intlekofer, A. M.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling
    Journal Article

    Guryanova, O. A.; Shank, K.; Spitzer, B.; Luciani, L.; Koche, R. P.; Garrett-Bakelman, F. E.; Ganzel, C.; Durham, B. H.; Mohanty, A.; Hoermann, G.; more...
    Nature Medicine (2016)

    Fulltext@MSK | Save
  • Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells
    Journal Article

    Guryanova, O. A.; Lieu, Y. K.; Garrett-Bakelman, F. E.; Spitzer, B.; Glass, J. L.; Shank, K.; Martinez, A. B. V.; Rivera, S. A.; Durham, B. H.; Rapaport, F.; more...
    Leukemia (2016)

    Fulltext@MSK | Save
  • Defining ATM-independent functions of the mre11 complex with a novel mouse model
    Journal Article

    Balestrini, A.; Nicolas, L.; Yang-Lott, K.; Guryanova, O. A.; Levine, R. L.; Bassing, C. H.; Chaudhuri, J.; Petrini, J. H. J.
    Molecular Cancer Research (2016)

    Fulltext@MSK | Save
  • Prmt5 negatively regulates erythropoiesis by multiple mechanisms, including controlling DNA methyltransferase 3A protein levels
    Meeting Abstract

    Hamard, P. J.; Luciani, L.; Liu, F.; Cheng, G. Y.; Hatlen, M. A.; Guryanova, O. A.; Zhao, X. Y.; Levine, R. L.; Nimer, S. D.
    Blood (2015)

    Fulltext@MSK | Save
  • DNMT3A R882 mutation promote chemoresistance and therapeutic relapse through impaired DNA-damage sensing
    Meeting Abstract

    Guryanova, O.; Shank, K.; Garrett-Bakelman, F.; Spitzer, B.; Ganzel, C.; Rapaport, F.; Keller, M.; Evangelista, L.; Glass, J.; Rowe, J.; more...
    Haematologica (2015)

    Fulltext@MSK | Save
  • CHZ868, a type II JAK2 inhibitor, reverses type I JAK inhibitor persistence and demonstrates efficacy in myeloproliferative neoplasms
    Journal Article

    Meyer, S.; Keller, M.; Chiu, S.; Koppikar, P.; Guryanova, O.; Rapaport, F.; Xu, K.; Manova, K.; Pankov, D.; O'reilly, R.; more...
    Cancer Cell (2015)

    Fulltext@MSK | Save
  • A WIMSical approach to decoding DNA methylation in myeloid leukemia
    Journal Article

    Guryanova, O. A.; Levine, R. L.
    Genome Biology (2014)

    Fulltext@MSK | Save
  • Characterizing transcriptional and epigenetic signatures induced by FLT3-ITD activation
    Meeting Abstract

    Spitzer, B.; Guryanova, O. A.; Abdel-Wahab, O.; Kucine, N.; Adli, M.; Berman, J. N.; Meshinchi, S.; Bernstein, B.; Pelossof, R.; Leslie, C.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Type II inhibition of JAK2 with NVP-CHZ868 reverses type I JAK inhibitor persistence and demonstrates increased efficacy in MPN models
    Meeting Abstract

    Meyer, S. C.; Keller, M. D.; Koppikar, P.; Guryanova, O. A.; Kleppe, M.; McKenney, A. S.; Sellers, W. R.; Hofmann, F.; Baffert, F.; Gaul, C.; more...
    Blood (2014)

    Fulltext@MSK | Save